Samir Gharib
Directeur Financier/CFO chez SPRUCE BIOSCIENCES, INC.
Fortune : 150 257 $ au 31/05/2024
Postes actifs de Samir Gharib
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Directeur Financier/CFO | 01/05/2020 | - |
| President | 01/01/2022 | - | |
| Cancer CAREpoint | Directeur/Membre du Conseil | 01/11/2017 | - |
Historique de carrière de Samir Gharib
Anciens postes connus de Samir Gharib
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Directeur Financier/CFO | 01/10/2018 | 01/09/2019 |
| Benchmark Financial Partners LLC | Corporate Officer/Principal | 01/09/2017 | 01/10/2018 |
| REVANCE THERAPEUTICS, INC. | Directeur Administratif | 01/10/2013 | 01/09/2017 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Comptroller/Controller/Auditor | 01/01/2011 | 01/09/2013 |
Formation de Samir Gharib
| Haas School of Business | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Health Technology |
| Cancer CAREpoint | |
| Benchmark Financial Partners LLC |
- Bourse
- Insiders
- Samir Gharib
- Expérience
